|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
FEZOLINETANT |
G02CX06 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
VUTRISIRAN |
N07XX18 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005852 |
15-09-2022 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
ZOLBETUXIMAB |
L01FX31 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005868 |
19-09-2024 |
VALID
|
|
ATOGEPANT |
N02CD07 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005871 |
11-08-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
CONCIZUMAB |
B02BX10 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/005938 |
13-12-2024 |
VALID
|
|
VIBEGRON |
G04BD15 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005957 |
27-06-2024 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
FR
|
II
|
29-10-2024 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
REPOTRECTINIB |
L01EX28 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006005 |
13-01-2025 |
VALID
|
|
ETRASIMOD |
L04AE05 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
ADAGRASIB |
L01XX77 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
CAPIVASERTIB |
L01EX27 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
RITLECITINIB |
L04AF08 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
DOPAMINE |
C01CA04 |
FR
|
I
|
|
EMEA/H/C/006044 |
27-05-2024 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
|
FLORTAUCIPIR (18F) |
V09AX07 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006064 |
22-08-2024 |
VALID
|
|
LAZERTINIB |
L01EB09 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006074 |
20-01-2025 |
VALID
|
|
IMETELSTAT |
L01XX80 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006105 |
07-03-2025 |
VALID
|
|
DELGOCITINIB |
D11AH11 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006109 |
19-09-2024 |
VALID
|
|
AZTREONAM AND BETA-LACTAMASE INHIBITOR |
J01DF51 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006113 |
22-04-2024 |
VALID
|
|
GARADACIMAB |
B06AC07 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006116 |
10-02-2025 |
VALID
|
|
TORIPALIMAB |
L01FF13 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006120 |
19-09-2024 |
VALID
|
|
VILOBELIMAB |
L04AJ10 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006123 |
13-01-2025 |
VALID
|
|
NEMOLIZUMAB |
D11AH12 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006149 |
12-02-2025 |
VALID
|
|
SERPLULIMAB |
L01FF12 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006170 |
03-02-2025 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
DASIGLUCAGON |
H04AA02 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006214 |
24-07-2024 |
VALID
|
|
ELAFIBRANOR |
A05AX06 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006231 |
19-09-2024 |
VALID
|
|
MARSTACIMAB |
B02BX11 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006240 |
19-09-2024 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
SIPAVIBART |
J06BD09 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006291 |
20-01-2025 |
VALID
|
|
EPLONTERSEN |
N07XX21 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006295 |
06-03-2025 |
VALID
|